(Q43535701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Persistence of anti-HBs 5 years after the introduction of routine infant and adolescent vaccination in Italy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Teresa Spadea

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

A Faustini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Sangalli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

R M Calabrese

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M Cauletti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C A Perucci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

20-22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

2812-2818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Duration and efficacy of immune response to hepatitis B vaccine in high-risk Chinese adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Hepatitis B vaccination: how long does protection last?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Kinetics of anti-HBs after hepatitis B vaccination: a comparison of two recombinant and one plasma-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Immunogenicity of hepatitis B vaccines among infant recipients of acellular and whole cell pertussis DTP vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Hepatitis B vaccination: how long does protection last?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Mass vaccination against hepatitis B in infants in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Prevention of horizontal transmission of hepatitis B: efficacy of hepatitis B immunoglobulin and vaccine in an institution for the handicapped

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Hepatitis B vaccines in patients with chronic renal failure before dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Hepatitis B vaccination in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Impaired response to hepatitis B vaccine in HIV infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Immunogenicity of hepatitis B vaccine in children with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Persistence of antibodies after immunization with a recombinant yeast-derived hepatitis B vaccine following two different schedules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or PreS2 + S antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Comparison of the immunogenicity, efficacy and safety of 10 micrograms and 20 micrograms of a hepatitis B vaccine: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Simultaneous administration of hepatitis B and diphtheria/tetanus/polio vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Effective antibody response in newborn babies living in Maldives to simultaneous vaccination against hepatitis B, poliomyelitis, diphtheria and tetanus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Newborn universal immunisation against hepatitis B: immunogenicity and reactogenicity of simultaneous administration of diphtheria/tetanus/pertussis (DTP) and oral polio vaccines with hepatitis B vaccine at 0, 2 and 6 months of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: is there need for a second dose of HBIg? Dutch Study Group on Prevention of Neonatal Hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Vaccines to prevent viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900005-6

7 January 2021

10.1016/S0264-410X(01)00005-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11282191%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference